Accelerating pooled licensing of medicines to enhance global production and equitable access
Author:
- 8 July 2022
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 400 (10352) , 632-634
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- It is not too late to achieve global covid-19 vaccine equityBMJ, 2022
- How COVID‐19 vaccine supply chains emerged in the midst of a pandemicThe World Economy, 2021
- Patent pooling to increase access to essential medicinesBulletin of the World Health Organization, 2019
- Essential medicines for universal health coverageThe Lancet, 2017
- Implementing Socially Responsible Licensing for Global Health: Beyond Neglected DiseasesScience Translational Medicine, 2014
- The Silent Epidemic of Exclusive University Licensing Policies on Compounds for Neglected Diseases and BeyondPLOS Neglected Tropical Diseases, 2010
- The UNITAID Patent Pool Initiative: Bringing Patents Together for the Common GoodThe Open AIDS Journal, 2010
- Towards a Patent Pool for HIV Medicines: The BackgroundThe Open AIDS Journal, 2010
- The market economy, and the scientific commonsResearch Policy, 2004